David Kelly
Analyst · SunTrust
Thanks, Joe. The results of KGS and our TraumaFX business have been reflected as discontinued operations and as assets held for sale in our first quarter 2019 consolidated financial statements. The total gain on the sale of KGS is approximately $72 million. The income tax benefit of $18.5 million or $0.74 per share was required to be recognized in the first quarter. Given the April 1 closing of the transaction, the remaining portion of the gain $53.5 million will be recognized in the second quarter. Net cash proceeds from the sale will be approximately $93 million. Revenue from continuing operations of $326.7 million in the quarter grew 4.6% year-over-year on a billing day basis. GAAP earnings per share from continuing operations of $0.32 were negatively impacted by $0.06 from severance and other costs, recognized as a result of actions to simplify the support structure of our business in anticipation of the KGS divestiture. Excluding these costs, earnings per share were $0.38, which improved nearly 19% on year-over-year basis. Our gross profit of 28.5% declined 70 basis points year-over-year primarily as a result of the decline in our Flex gross profit percentage. Tech Flex margins of 25.3% declined 80 basis points year-over-year. As noted last quarter, we've experienced spread compression in Tech Flex as a result of the mix of growth in some of our larger clients, which have a slightly lower margin profile. As we look to the future, we expect to continue to be more -- to more deeply penetrate our existing clients. This may create slight margin pressure as our pricing strategies structures typically include tiered discounts for greater volume at our largest clients. However, our continued efforts in overall portfolio management should mitigate much of this impact. As importantly, greater scale at individual clients allows our associates and support infrastructure to be more efficient and drive profitability from these clients that is accretive to our operating margin targets even at slightly lower growth margins. SG&A expenses adjusted for the $2 million of severance and other costs resulting from the divestiture of KGS, declined as a percentage of revenue by 100 basis points year-over-year. We continue to make progress in generating SG&A leverage as revenues expand. This leverage has been achieved, while also significantly increasing our technology investments. We are also aggressively pursuing opportunities to partner with leading technology firms to embrace applications that enhance our customer experience and further improve productivity and strengthen client and consultant relationships. Our first quarter operating margin, excluding severance and other costs, was 4.2%, which has improved 40 basis points year-over-year and met our expectations. During this economic cycle, our gross margin percentage has declined by approximately 200 basis points. Despite this compression, operating margins have improved by more than 400 basis points. Our effective tax rate in the first quarter from continuing operations was 26.1%. Operating cash flows in the first quarter, which is typically our lowest quarter of the year, were $11.8 million. Based upon current trends operating cash flows in 2019 could reach approximately $85 million, excluding any proceeds from the sale of our KGS and TraumaFX businesses. We repurchased 430,000 shares of stock at a total cost of $14.6 million during the quarter and have continued to be active in repurchasing our shares subsequent to the end of the quarter. We expect to continue these activities until the net proceeds from the divestiture of KGS have been exhausted. As of yesterday, the remaining net proceeds yet to be deployed were $78 million. Long-term debt under our credit facility was $82.5 million as of March 31. We expect to maintain debt levels for the remainder of 2019 at $65 million, which is a notional amount of our attractive interest rate hedge. Depending upon the extent of our operating cash flows and pace of stock repurchases, we expect to be in a net cash position for the remainder of 2019. Our healthy cash flows, minimal CapEx requirements, low debt levels and $300 million credit facility collectively provide us maximum flexibility to execute quickly on strategic or tuck-in acquisitions or other ventures and strategic partnerships even while aggressively repurchasing stock. I wanted to provide you a sense of how our weighted average shares outstanding could trend for the remainder of 2019, given current repurchase trends. Based upon Q1 activity, we forecast being able to deploy between $20 million and $25 million in cash per quarter. This would result in weighted average diluted shares outstanding of approximately $24.5 million in Q2, $23.9 million in Q3 and $23.3 million in Q4. Actual results, of course, could vary significantly depending upon stock price and volume. Our billing days are 64 days in the second quarter, which is equal to the second quarter of 2018. With respect to guidance for continuing operations, we expect Q2 revenues to be in the range of $338 million to $343 million and for earnings per share to be between $0.64 and $0.66. Gross margins are expected to be between 29.7% and 29.9%, while Flex margins are expected to be between 27% and 27.2%. This includes an expected sequential improvement from seasonal payroll taxes of 100 basis points. SG&A as a percentage of revenue is expected to be between 22.8% and 23%, and operating margin should be between 6.3% and 6.5%. Guidance assumes an effective tax rate of 26%. Weighted average diluted shares outstanding, as I mentioned, are expected to be approximately $24.5 million in Q2. This guidance does not consider the effect, if any, of charges related to any onetime costs, costs or charges related to any pending tax or legal matters, the impact on revenues of any disruption in government funding or the firms response towards regulatory, legal or future tax law changes. We are pleased with continued above-market performance in our Tech Flex business and are focused on repositioning our FA Flex business as we previously discussed. Subsequent to the sale of KGS, we now expect operating margins to be 6.5% or better in a quarter without seasonality effects where revenues are $350 million, which could occur as early as the third quarter. We expect profitability levels to continue to improve to 7.7% in a $400 million quarter. This is a 20 basis point improvement from the 6.3% and 7.5% at the same revenue levels in models provided prior to the divestiture of KGS. Costs related to seasonality impact our first and fourth quarters each year by approximately 180 basis points and 40 basis points, respectively. We continue to be excited about our prospects in the market for our services, which remain quite strong and remain -- and we remain confident that we built a solid foundation for sustained revenue growth and continued improvements in profitability. Demetrius, we'll now open the call up for questions.